Sun Pharma sees FY12 revenue rising 28-30%

Sun Pharmaceutical Industries expects revenue to rise 28-30% in the year ending March 2012, a top company official said on Monday.

May 30, 2011 / 12:02 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Sun Pharmaceutical Industries expects revenue to rise 28-30% in the year ending March 2012, a top company official said on Monday.

Revenue in 2010/11 had climbed 43% to Rs 5,721 crore (USD 1.3 billion).

The company also plans to spend Rs 4,500 crore in capital expenditure for the current fiscal year, Chairman and Managing Director Dilip Shanghvi said on an earnings call.

Over the weekend, the Mumbai-based drugmaker reported a better-than-expected 12% rise in net profit for the quarter ended March.

first published: May 30, 2011 11:08 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347